tiprankstipranks
Trending News
More News >
SynAct Pharma AB (SE:SYNACT)
:SYNACT
Sweden Market

SynAct Pharma AB (SYNACT) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
16Bullish
4Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
SynAct Pharma AB’s (SYNACT) Moving Averages Convergence Divergence (MACD) indicator is 0.30, suggesting SynAct Pharma AB is a Sell.
SynAct Pharma AB’s (SYNACT) 20-Day exponential moving average is 21.76, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Buy.
SynAct Pharma AB’s (SYNACT) 50-Day exponential moving average is 21.49, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Buy.

SynAct Pharma AB (SYNACT) Pivot Points

Jan 13, 2026, 04:20 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
20.22
20.73
21.47
21.98
22.72
23.23
23.97
Fibonacci
20.73
21.21
21.51
21.98
22.46
22.76
23.23
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

SynAct Pharma AB (SYNACT) Moving Averages

Jan 13, 2026, 04:20 AM
Period
Simple
Exponential
MA5
21.94Buy
22.24Buy
MA10
22.36Buy
22.04Buy
MA20
21.54Buy
21.76Buy
MA50
21.52Buy
21.49Buy
MA100
21.01Buy
20.99Buy
MA200
19.88Buy
19.54Buy
SynAct Pharma AB’s (SYNACT) 10-Day exponential moving average is 22.04, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Buy.
SynAct Pharma AB’s (SYNACT) 100-Day exponential moving average is 20.99, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Buy.
SynAct Pharma AB’s (SYNACT) stock price is kr23.8 and SynAct Pharma AB’s (SYNACT) 50-day simple moving average is 21.52, creating a Buy signal.
SynAct Pharma AB’s (SYNACT) stock price is kr23.8 and SynAct Pharma AB’s (SYNACT) 100-day simple moving average is 21.01, creating a Buy signal.
SynAct Pharma AB’s (SYNACT) stock price is kr23.8 and SynAct Pharma AB’s (SYNACT) 200-day simple moving average is 19.88, creating a Buy signal.

SynAct Pharma AB (SYNACT) Technical Indicators

Jan 13, 2026, 04:20 AM
Name
Value
Implied Action
RSI (14)
58.00
Neutral
STOCH (9,6)
46.57
Neutral
STOCHRSI (14)
53.70
Neutral
MACD (12,26)
0.30
Sell
ADX (14)
14.30
Buy
Williams %R
-36.01
Buy
CCI (14)
109.13
Sell
ATR (14)
1.11
-
Ultimate Oscillator
52.71
Neutral
ROC
10.71
Buy
SynAct Pharma AB’s (SYNACT) Relative Strength Index (RSI) is 58.00, creating a Neutral signal.
SynAct Pharma AB’s (SYNACT) Trend Strength Indicator (ADX) is 14.30, creating a Buy signal.
SynAct Pharma AB’s (SYNACT) Commodity Channel Index (CCI) is 109.13, creating a Sell signal.
SynAct Pharma AB’s (SYNACT) Price Rate of Change (ROC) is 10.71, creating a Buy signal.

FAQ

Is SYNACT a Buy, Hold, or Sell?
Based on SYNACT’s technical indicators, SYNACT is a Strong Buy.
    What is SYNACT’s RSI (14)?
    SYNACT’s RSI (14) is 58.00, which suggests SYNACT is a Neutral.
      What is SYNACT’s MACD?
      SYNACT’s MACD is 0.30, which suggests SYNACT is a Sell.
        What is SYNACT’s 5-day moving average?
        SYNACT’s 5-day moving average is 21.94, which suggests SYNACT is a Buy.
          What is SYNACT’s 20-day moving average?
          SYNACT 20-day moving average is 21.54, which suggests SYNACT is a Buy.
            What is SYNACT’s 50-day moving average?
            SYNACT’s 50-day moving average is 21.52, which suggests SYNACT is a Buy.
              What is SYNACT’s 200-day moving average?
              SYNACT’s 200-day moving average is 19.88, which suggests SYNACT is a Buy.
                What is SYNACT’s Williams % R (14)?
                SYNACT’s Williams % R (14) is -36.01, which suggests SYNACT is a Buy.
                  What is SYNACT’s CCI (14)?
                  SYNACT’s CCI (14) is 109.13, which suggests SYNACT is a Sell.
                    What is the share price of SynAct Pharma AB?